Skip to main content
Top
Published in: Clinical Rheumatology 3/2006

01-05-2006 | Case Report

Shrinking lung syndrome as a presenting manifestation of systemic lupus erythematosus in a female Kuwaiti

Authors: Haneen Adel Al-Raqum, Sukhbir Singh Uppal, Moudi Al-Mutairy, Rakesh Kumari

Published in: Clinical Rheumatology | Issue 3/2006

Login to get access

Abstract

The shrinking lung syndrome (SLS) is a rare manifestation in patients with established systemic lupus erythematosus (SLE). Only two cases have been reported in which this syndrome was the presenting manifestation of SLE. We describe a 21-year-old female Kuwaiti who presented with SLS. In addition to clinical and serological features of lupus, she had dyspnea, respiratory muscle dysfunction, characteristic chest radiographic findings of small lung volumes, elevated right hemidiaphragm, and basilar atelectasis. There was no pulmonary parenchymal or pulmonary vascular involvement. Nerve conduction study showed right phrenic nerve palsy. She responded well to treatment with corticosteroids.
Literature
1.
go back to reference Branger S, Schleinitz N, Gayet S, Veit V, Kaplanski G, Badier M, Magnan A, Harle JR (2004) Shrinking lung syndrome and systemic auto-immune disease. Rev Med Interne 25:83–90CrossRefPubMed Branger S, Schleinitz N, Gayet S, Veit V, Kaplanski G, Badier M, Magnan A, Harle JR (2004) Shrinking lung syndrome and systemic auto-immune disease. Rev Med Interne 25:83–90CrossRefPubMed
2.
go back to reference Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef
3.
go back to reference Stevens WM, Burdon JG, Clemens LE, Webb J (1990) The ‘shrinking lungs syndrome’—an infrequently recognised feature of systemic lupus erythematosus. Aust N Z J Med 20:67–70PubMed Stevens WM, Burdon JG, Clemens LE, Webb J (1990) The ‘shrinking lungs syndrome’—an infrequently recognised feature of systemic lupus erythematosus. Aust N Z J Med 20:67–70PubMed
4.
go back to reference Chick TW, DeHoratius RJ, Skipper BE, Messner RP (1976) Pulmonary dysfunction in systemic lupus erythematosus without pulmonary symptoms. J Rheumatol 3:262–268PubMed Chick TW, DeHoratius RJ, Skipper BE, Messner RP (1976) Pulmonary dysfunction in systemic lupus erythematosus without pulmonary symptoms. J Rheumatol 3:262–268PubMed
5.
go back to reference Raj R, Murin S, Matthay RA, Wiedemann HP (2002) Systemic lupus erythematosus in the intensive care unit. Crit Care Clin 18:781–803CrossRefPubMed Raj R, Murin S, Matthay RA, Wiedemann HP (2002) Systemic lupus erythematosus in the intensive care unit. Crit Care Clin 18:781–803CrossRefPubMed
6.
go back to reference Hardy K, Herry I, Attali V, Cadranel J, Similowski T (2001) Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest 119:1274–1277CrossRefPubMed Hardy K, Herry I, Attali V, Cadranel J, Similowski T (2001) Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest 119:1274–1277CrossRefPubMed
7.
go back to reference Laroche CM, Mulvey DA, Hawkins PN, Walport MJ, Strickland B, Moxham J, Green M (1989) Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q J Med 71:429–439PubMed Laroche CM, Mulvey DA, Hawkins PN, Walport MJ, Strickland B, Moxham J, Green M (1989) Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q J Med 71:429–439PubMed
8.
go back to reference Rubin LA, Urowitz MB (1983) Shrinking lung syndrome in SLE—a clinical pathologic study. J Rheumatol 10:973–976PubMed Rubin LA, Urowitz MB (1983) Shrinking lung syndrome in SLE—a clinical pathologic study. J Rheumatol 10:973–976PubMed
Metadata
Title
Shrinking lung syndrome as a presenting manifestation of systemic lupus erythematosus in a female Kuwaiti
Authors
Haneen Adel Al-Raqum
Sukhbir Singh Uppal
Moudi Al-Mutairy
Rakesh Kumari
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0020-5

Other articles of this Issue 3/2006

Clinical Rheumatology 3/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine